This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Vision Expo 2023 – Stand 12
Cellular reprogramming
About our research
Photoreceptors are tiny light sensing cells at the back of the eye. When they are damaged, vision loss and blindness occurs and there is currently no way to restore damaged cells once they are lost.
Our research aims to develop a new regenerative therapy to restore damaged photoreceptors and save the sight of people with retinal diseases. This has the potential to help more than 190 million people worldwide with retinal diseases including retinitis pigmentosa, Stargardt’s disease and age-related macular degeneration (AMD).
What you’ll see
Under a microscope, you’ll see human retinal cells that we have generated in the lab using stem cell technologies.
Talk to us about
- Can we regenerate the retina to treat blindness caused by retinal degenerative diseases?
- Can we use new gene editing technology to develop gene therapy for inherited retinal diseases (IRDs)?
- What are the signals that support retinal cells for healthy vision?